Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2019 Does a Patient’s Trauma History Ethically Justify a Discriminatory Clinical Referral? John R. Stone, MD, PhD A “simplicity strategy” suggests expressing respect for persons and empathy and models inclusive group inquiry, epistemic humility, and justice. AMA J Ethics. 2019;21(6):E493-498. doi: 10.1001/amajethics.2019.493. Case and Commentary Sep 2022 What Do We Owe Health Workers Earning Low Wages Who Are at Risk of Harm? Constance E. George, MD, MA Psychiatric aides and technicians are part of direct care workforces in inpatient units who are subject to high rates of violence but earn far less than higher-status clinicians. AMA J Ethics. 2022;24(9):E830-838. doi: 10.1001/amajethics.2022.830. Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505. State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Jun 2019 Does a Patient’s Trauma History Ethically Justify a Discriminatory Clinical Referral? John R. Stone, MD, PhD A “simplicity strategy” suggests expressing respect for persons and empathy and models inclusive group inquiry, epistemic humility, and justice. AMA J Ethics. 2019;21(6):E493-498. doi: 10.1001/amajethics.2019.493.
Case and Commentary Sep 2022 What Do We Owe Health Workers Earning Low Wages Who Are at Risk of Harm? Constance E. George, MD, MA Psychiatric aides and technicians are part of direct care workforces in inpatient units who are subject to high rates of violence but earn far less than higher-status clinicians. AMA J Ethics. 2022;24(9):E830-838. doi: 10.1001/amajethics.2022.830.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 1 J. Wesley Boyd, MD, PhD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 2 John Dunlop, MD Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
Case and Commentary May 2005 The Evangelizing Patient, Commentary 3 Harold G. Koenig, MD, MHSc Virtual Mentor. 2005;7(5):359-366. doi: 10.1001/virtualmentor.2005.7.5.ccas4-0505.
State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.